Stay updated on Safety Tolerability in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability in IPF Clinical Trial page.

Latest updates to the Safety Tolerability in IPF Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision label updated from v3.6.5 to v3.6.6, indicating a new build of the Study Details page. It does not alter study content, eligibility criteria, or results.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays the full study record for NCT02503657 (MN-001-IPF-201), including the overview, design, eligibility criteria, outcomes, enrollment details, and locations. This brings the complete IPF trial information back online for users seeking study specifics.SummaryDifference52%

- Check40 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new build of the page. This update appears to be a minor patch rather than changes to the study details or content.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.6.4 replaces the prior Revision: v3.6.3, indicating a minor update to the page's metadata. This change does not modify study details, eligibility criteria, or any user-facing content.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.6.3 is now shown on the page, replacing Revision: v3.6.2, indicating a minor internal update to the page version without altering study details or public content.SummaryDifference0.1%

- Check83 days agoChange DetectedFooter revision tag updated from Revision: v3.6.0 to Revision: v3.6.2, reflecting a newer build of the page. This represents a minor template/version update rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Safety Tolerability in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability in IPF Clinical Trial page.